Briacell Therapeutics Corp saw a notable uptick in its stock price, reflecting investor optimism.
Briacell Therapeutics Corp (BCT.TO) experienced a significant rise in its stock price yesterday, closing at CA$5.14, which marks an increase of 6.64%. This surge comes amid ongoing developments in the biotechnology sector, which continue to attract investor interest.
Advertisement
Briacell Therapeutics Corp
BCT.TO
BCT.TO
Briacell Therapeutics Corp
WealthAwesomeMarket cap
$41.93M
52W high
$20.40
52W low
$3.68
1W change
+5.98%
Beta
1.52
Analyst Price Targets
Based on analyst covering BCT
Wall Street analysts forecast BCT stock price to rise 289.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.00
+289.1% Upside
Current Price
C$5.14
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BCT's historical volatility
30-Day Vol
75.7%
Annualized
90-Day Vol
86.9%
Annualized
Trend (90d)
+9.1%
Annualized drift
90d Mean
C$5.31
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$5.20 | C$4.00 โ C$6.75 |
| 60 trading days | C$5.25 | C$3.63 โ C$7.60 |
| 90 trading days | C$5.31 | C$3.38 โ C$8.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep an eye on Briacell's strategic moves and market positioning, especially as it navigates the complexities of the biotech landscape.
Briacell's stock jumped 6.64% yesterday
Advertisement
With a market cap of CA$41.93 million, Briacell's recent performance highlights its potential for growth in the competitive biotech market.
Bull case
The recent surge could indicate growing confidence in Briacell's future, especially after its announcements about share consolidation and public offerings aimed at raising capital for upcoming projects. Investors might see this as a positive sign of the company's commitment to growth and innovation.
Bear case
Despite the positive movement, investors should stay cautious. The biotech sector can be unpredictable, and any setbacks in clinical trials or financial performance could quickly reverse these gains. It's essential to keep in mind the risks involved with biotech investments.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
